(8-001) Budget Impact of Subcutaneous Immunoglobulin, Intravenous Immunoglobulin and Efgartigimod Alfa in Patients with Chronic Inflammatory Demyelinating Polyneuropathy in the United States
Tuesday, December 10, 2024
2:00 PM – 3:30 PM
Location: Hall G, Lower Level
Category: Evaluative Study Topic: Administrative Practice/Management/Financial Management/Human Resources
Co-Author(s): Rajiv Mallick, Rashad Carlton, Joris van Stiphout, Betsy Lahue
